NCT00777582 2026-01-13Phase I Comparative Bioavailability StudyAstraZenecaPhase 1 Active not recruiting197 enrolled
NCT00819221 2022-08-30AZD2281 in Combination With Liposomal Doxorubicin in Advanced Solid TumoursAstraZenecaPhase 1 Terminated44 enrolled